Shinva Medical Instrument Co., Ltd.

Shanghai Stock Exchange 600587.SS

Shinva Medical Instrument Co., Ltd. EBITDA Margin for the year ending December 31, 2023: 9.67%

Shinva Medical Instrument Co., Ltd. EBITDA Margin is 9.67% for the year ending December 31, 2023, a 8.04% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Shinva Medical Instrument Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 8.95%, a -17.18% change year over year.
Shinva Medical Instrument Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 10.80%, a 49.38% change year over year.
Shinva Medical Instrument Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was 7.23%, a -57.06% change year over year.
Shinva Medical Instrument Co., Ltd. EBITDA Margin for the year ending December 31, 2019 was 16.84%, a 179.96% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Shanghai Stock Exchange: 600587.SS

Shinva Medical Instrument Co., Ltd.

CEO	Mr. Baoxian Gong
IPO Date	Sept. 27, 2002
Location	China
Headquarters	No. 7 Taimei Road
Employees	8,209
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.

Key trends

Past 5 years